Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?

This paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and circulating tumor DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, and resistance to chemotherapy. This paper reviews various CTCs and ct DNA...

Full description

Saved in:
Bibliographic Details
Main Authors: Felix Wong, Bee Luan Khoo, Karen Kar Loen Chan
Format: Article
Language:English
Published: IMR Press 2023-06-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/50/6/10.31083/j.ceog5006132
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849435167604604928
author Felix Wong
Bee Luan Khoo
Karen Kar Loen Chan
author_facet Felix Wong
Bee Luan Khoo
Karen Kar Loen Chan
author_sort Felix Wong
collection DOAJ
description This paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and circulating tumor DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, and resistance to chemotherapy. This paper reviews various CTCs and ct DNA studies in the literature about their applications in gynecological cancers. Hopefully, further translational cancer research in gynecology will enable personalized cancer treatment to become a realistic expectation.
format Article
id doaj-art-577ef1ade105453bb39a62eb85fc1eb9
institution Kabale University
issn 0390-6663
language English
publishDate 2023-06-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-577ef1ade105453bb39a62eb85fc1eb92025-08-20T03:26:24ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632023-06-0150613210.31083/j.ceog5006132S0390-6663(23)02074-2Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?Felix Wong0Bee Luan Khoo1Karen Kar Loen Chan2Women and Babies Clinic, Central Building, Hong Kong, ChinaDepartment of Biomedical Engineering, City University of Hong Kong, Hong Kong, ChinaDepartment of Obstetrics & Gynecology, Hong Kong University, Hong Kong, ChinaThis paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and circulating tumor DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, and resistance to chemotherapy. This paper reviews various CTCs and ct DNA studies in the literature about their applications in gynecological cancers. Hopefully, further translational cancer research in gynecology will enable personalized cancer treatment to become a realistic expectation.https://www.imrpress.com/journal/CEOG/50/6/10.31083/j.ceog5006132gynecological cancersliquid biopsycirculating tumor cellscirculating tumor dna
spellingShingle Felix Wong
Bee Luan Khoo
Karen Kar Loen Chan
Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
Clinical and Experimental Obstetrics & Gynecology
gynecological cancers
liquid biopsy
circulating tumor cells
circulating tumor dna
title Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
title_full Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
title_fullStr Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
title_full_unstemmed Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
title_short Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
title_sort can liquid biopsy cancer research offering personalized cancer treatment in gynecology be a realistic expectation
topic gynecological cancers
liquid biopsy
circulating tumor cells
circulating tumor dna
url https://www.imrpress.com/journal/CEOG/50/6/10.31083/j.ceog5006132
work_keys_str_mv AT felixwong canliquidbiopsycancerresearchofferingpersonalizedcancertreatmentingynecologybearealisticexpectation
AT beeluankhoo canliquidbiopsycancerresearchofferingpersonalizedcancertreatmentingynecologybearealisticexpectation
AT karenkarloenchan canliquidbiopsycancerresearchofferingpersonalizedcancertreatmentingynecologybearealisticexpectation